Table 1.
Patient's demographics, comorbidities, symptoms and laboratory findings at admission
| All patients (n, 98) | Discharged at home (n = 39) | Hospitalized and stable (n = 35) | Hospitalized in serious condition or died (n = 24) | p value | Effect | |
|---|---|---|---|---|---|---|
| Age | 61.0 (23.0–91.0) | 56.0 (26.0–83.0) | 62.0 (23.0–91.0) | 78.50 (48.0–89.0) | < 0.001 | ↑ |
| Gender | ||||||
| Male | 59 (60.20%) | 22 (56.41%) | 21 (60.0%) | 16 (66.7%) | > 0.05 | |
| Female | 39 (39.80%) | 17 (43.59%) | 14 (40.0%) | 8 (33.3%) | ||
| Symptoms | ||||||
| Fever | 90 (91.83%) | 36 (92.31%) | 35 (100.0%) | 19 (79.17%) | > 0.05 | |
| Cough | 69 (70.40%) | 30 (76.92%) | 24 (68.57%) | 15 (62.50%) | > 0.05 | |
| Respiratory failure | 9 (9.18%) | 1 (2.56%) | 3 (8.57%) | 5 (20.83%) | > 0.05 | |
| Dyspnea | 52 (53.06%) | 22 (56.41%) | 17 (48.57%) | 13 (54.17%) | > 0.05 | |
| Asthenia | 11 (11.22%) | 7 (17.95%) | 3 (8.57%) | 1 (4.17%) | > 0.05 | |
| Other (arthralgia, diarrhea, leukopenia, nausea) | 8 (8.16%) | 3 (7.69%) | 4 (11.42%) | 1 (4.17%) | > 0.05 | |
| Comorbidities | ||||||
| Hypertension | 42 (42.86%) | 18 (46.15%) | 11 831.43%) | 13 (54.17%) | > 0.05 | |
| Diabetes | 12 (12.24%) | 5 (12.82%) | 4 (11.42%) | 3 (12.50%) | > 0.05 | |
| Neurological | 9 (9.18%) | 3 (7.69%) | 2 (5.71%) | 4 (16.17%) | > 0.05 | |
| Cardiovascular | 5 (5.10%) | 0 (0.0%) | 1 (2.86%) | 4 (16.17%) | > 0.05 | |
| Oncological | 9 (9.18%) | 3 (7.69%) | 3 (8.57%) | 3 (12.50%) | > 0.05 | |
| Pulmonary | 8 (8.16%) | 2 (5.13%) | 2 (5.71%) | 4 (16.17%) | > 0.05 | |
| Laboratory findings | ||||||
| SpO2 (%) | 93 (72–99) | 94 (81–99) | 94 (80–98) | 89 (72–95) | < 0.001 | ↓ |
| HS CRP (mg/dL) | 8.41 (0.04–32.90) | 7.38 (0.04–32.0) | 7.4 (0.25–24.35) | 14.65 (2.37–27.0) | < 0.01 | ↑ |
| Leukocyte (103 µL) | 6.20 (1.60–25.10) | 6.40 (2.70–21.0) | 5.70 (2.60–9.20) | 6.45 (1.60–25.10) | 0.03 | ↑ |
| Lymphocytes (%) | 15.2 (2.40–51.40) | 17.20 (4.10–44.60) | 14.60 (6.60–51.40) | 11.20 (2.40–24.0) | > 0.05 | |
| Neutrophils (%) | 77.55 (35.20–95.40) | 74.90 (44.70–91.50) | 78.70 (35.20–87.90) | 81.85 (60.20–95.40) | 0.05 | ↑ |
| Procalcitonin (ng mL) cutoff 0.08 (%) | 0.08 (0.01–15.80) | 0.08 (0.01–1.29) | 0.08 (0.02–15.80) | 0.30 (0.03–6.60) | > 0.05 | |
| LDH (IU/L) | 323.0 (112.0–156.6.0) | 309.0 (112.0–687.0) | 309.0 (142.0–541.0) | 393.0 (194.0–1566.0) | < 0.001 | ↑ |
| d-dimer (mg/L) | 0.96 (0.21–35.0) | 0.87 (0.24–8.0) | 0.60 (0.26–2.94) | 1.43 (0.21–35.0) | 0.01 | ↑ |
| Lactates (IU/L) | 1.20 (0.0–11.0) | 1.10 (1.0–2.0) | 1.10 (0.0–2.0) | 1.50 (1.0–11.0) | > 0.05 | |
| Troponin (mg/mL) | 9.90 (0.0—297.0) | 7.30 (0.0–59.0) | 6.05 (1.0–84.0) | 23.75 (1.0–297.0) | < 0.001 | ↑ |
| Creatinine (mg/dL) | 0.90 (0.50–6.40) | 0.90 (0.50–1.80) | 0.77 (0.53–2.40) | 1.19 (0.70–6.40) | < 0.001 | ↑ |
| Azotemia (mg/dL) | 35.0 (16.0–409.0) | 32.50 (17.0–126.0) | 30.0 (16.0–71.0) | 57.0 (25.0–409.0) | < 0.001 | ↑ |
| Glicemia (mg/dL) | 106.0 (68.0–705.0) | 105.0 (68.0–705.0) | 103.0 (74.0–233.0) | 118.0 (87.0–342.0) | > 0.05 | |
| ALT (IU/L) | 29.0 (7.0–379.0) | 21.5 (10.0–152.0) | 29.0 (9.0–120.0) | 32.50 (7.0–379.0) | 0.04 | ↑ |
| AST (IU/L) | 38.0 (12.0–407.0) | 32.50 (12.0–116.0) | 33.0 (14.0–98.0) | 51.0 (14.0–407.0) | < 0.01 | ↑ |
| Bilirubin (mg/dL) | 0.50 (0.10–4.30) | 0.50 (0.10–1.20) | 0.50 (0.20–1.20) | 0.55 (0.20–4.30) | 0.05 | ↑ |
| Prothrombin time (s) | 8.99 (7.40–28.78) | 8.89 (8.16–11.25) | 9.24 (7.40–26.14) | 9.13 (8.34–28.78) | > 0.05 | |
| Partial thromboplastin time (s) | 32.20 (20.0–89.50) | 31.25 (20.0–38.50) | 32.40 (25.40–49.40) | 33.35 (23.80–89.50) | > 0.05 | |
| Fibrinogen (mg/dL) | 510.0 (99.0–905.0) | 487.0 (240.0–905.0) | 525.0 (257.0–830.0) | 508.5 (99.0–835.0) | > 0.05 | |
| Sodium (mmol/L) | 137.0 (123.0–152.0) | 136.0 (123.0–142.0) | 138.0 (131.0–152.0) | 136.50 (125.0–152.0) | > 0.05 | |
Categorical variables are expressed as counts and percentage in parenthesis. Continuous variables are shown as median and range in parenthesis
Significant p values (< 0.05) are showed in bold type
HS-CRP High sensitivity C-reactive protein, LDH lactate dehydrogenase